Guilmeau S - Search Results

1

Dysregulated CRTC1 activity is a novel component of PGE2 signaling that contributes to colon cancer growth.

Schumacher Y, Aparicio T, Ourabah S, Baraille F, Martin A, Wind P, Dentin R, Postic C, Guilmeau S. Schumacher Y, et al. Among authors: guilmeau s. Oncogene. 2016 May 19;35(20):2602-14. doi: 10.1038/onc.2015.283. Epub 2015 Aug 24. Oncogene. 2016. PMID: 26300003

2

Leptin counteracts sodium butyrate-induced apoptosis in human colon cancer HT-29 cells via NF-kappaB signaling.

Rouet-Benzineb P, Aparicio T, Guilmeau S, Pouzet C, Descatoire V, Buyse M, Bado A. Rouet-Benzineb P, et al. Among authors: guilmeau s. J Biol Chem. 2004 Apr 16;279(16):16495-502. doi: 10.1074/jbc.M312999200. Epub 2004 Jan 29. J Biol Chem. 2004. PMID: 14752104 Free article.

3

Leptin reduces the development of the initial precancerous lesions induced by azoxymethane in the rat colonic mucosa.

Aparicio T, Guilmeau S, Goiot H, Tsocas A, Laigneau JP, Bado A, Sobhani I, Lehy T. Aparicio T, et al. Among authors: guilmeau s. Gastroenterology. 2004 Feb;126(2):499-510. doi: 10.1053/j.gastro.2003.11.004. Gastroenterology. 2004. PMID: 14762787

4

Heterogeneity of Jagged1 expression in human and mouse intestinal tumors: implications for targeting Notch signaling.

Guilmeau S, Flandez M, Mariadason JM, Augenlicht LH. Guilmeau S, et al. Oncogene. 2010 Feb 18;29(7):992-1002. doi: 10.1038/onc.2009.393. Epub 2009 Nov 23. Oncogene. 2010. PMID: 19935714

5

Notch signaling and intestinal cancer.

Guilmeau S. Guilmeau S. Adv Exp Med Biol. 2012;727:272-88. doi: 10.1007/978-1-4614-0899-4_21. Adv Exp Med Biol. 2012. PMID: 22399355 Review.

6

Novel insights into ChREBP regulation and function.

Filhoulaud G, Guilmeau S, Dentin R, Girard J, Postic C. Filhoulaud G, et al. Among authors: guilmeau s. Trends Endocrinol Metab. 2013 May;24(5):257-68. doi: 10.1016/j.tem.2013.01.003. Epub 2013 Apr 15. Trends Endocrinol Metab. 2013. PMID: 23597489 Review.

7

Gastric bypass surgery in NASH: a major modulator of hepatic mitochondrial dysfunction.

Baraille F, Guilmeau S, Postic C. Baraille F, et al. Among authors: guilmeau s. Gut. 2015 Apr;64(4):524-6. doi: 10.1136/gutjnl-2014-307738. Epub 2014 Jul 30. Gut. 2015. PMID: 25080449 No abstract available.

8

Integration of ChREBP-Mediated Glucose Sensing into Whole Body Metabolism.

Baraille F, Planchais J, Dentin R, Guilmeau S, Postic C. Baraille F, et al. Among authors: guilmeau s. Physiology (Bethesda). 2015 Nov;30(6):428-37. doi: 10.1152/physiol.00016.2015. Physiology (Bethesda). 2015. PMID: 26525342 Free article. Review.

9

Novel Grb14-Mediated Cross Talk between Insulin and p62/Nrf2 Pathways Regulates Liver Lipogenesis and Selective Insulin Resistance.

Popineau L, Morzyglod L, Carré N, Caüzac M, Bossard P, Prip-Buus C, Lenoir V, Ragazzon B, Fauveau V, Robert L, Guilmeau S, Postic C, Komatsu M, Canonne-Hergaux F, Guillou H, Burnol AF. Popineau L, et al. Among authors: guilmeau s. Mol Cell Biol. 2016 Jul 29;36(16):2168-81. doi: 10.1128/MCB.00170-16. Print 2016 Aug 15. Mol Cell Biol. 2016. PMID: 27215388 Free PMC article.

10

Growth factor receptor binding protein 14 inhibition triggers insulin-induced mouse hepatocyte proliferation and is associated with hepatocellular carcinoma.

Morzyglod L, Caüzac M, Popineau L, Denechaud PD, Fajas L, Ragazzon B, Fauveau V, Planchais J, Vasseur-Cognet M, Fartoux L, Scatton O, Rosmorduc O, Guilmeau S, Postic C, Desdouets C, Desbois-Mouthon C, Burnol AF. Morzyglod L, et al. Among authors: guilmeau s. Hepatology. 2017 Apr;65(4):1352-1368. doi: 10.1002/hep.28972. Epub 2017 Feb 21. Hepatology. 2017. PMID: 27981611

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43 results

Search Page

Filters